REVIEW

Update on childhood rhabdomyosarcoma

H P McDowell

Correspondence to:
Correspondence to:
H P McDowell, RLC NHS Trust Alder Hey, Liverpool, UK Dr H P McDowell, Consultant Paediatric Oncologist, RLC NHS Trust Alder Hey, Eaton Road, Liverpool L12 2AP, UK;
Heather.McDowell{at}RLCH.NWEST.NHS.UK

The overall survival of childhood rhabdomyosarcoma has improved dramatically over the past 10 years. Early diagnosis and appropriate referral to a specialised centre leading to an accurate and timely diagnosis reflects on overall outcome. Recent molecular studies have identified different biological subtypes resulting in the recognition of poorer subgroups and allowing more appropriate treatment to be administered. Clinical trials remain the cornerstone to further improve outcome, now carried out on an international basis.

Keywords: rhabdomyosarcoma; survival; chemotherapy

Abbreviations: EFS, event free survival; OS, overall survival; RMS, rhabdomyosarcoma

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Laffan, E. E., Ngan, B.-Y., Navarro, O. M. (2009). Pediatric Soft-Tissue Tumors and Pseudotumors: MR Imaging Features with Pathologic Correlation: Part 2. Tumors of Fibroblastic/Myofibroblastic, So-called Fibrohistiocytic, Muscular, Lymphomatous, Neurogenic, Hair Matrix, and Uncertain Origin1. RadioGraphics 29: e36-e36 [Abstract] [Full Text]  
• Laffan, E. E., Ngan, B.-Y., Navarro, O. M. (2009). Pediatric Soft-Tissue Tumors and Pseudotumors: MR Imaging Features with Pathologic Correlation: Part 2. Tumors of Fibroblastic/Myofibroblastic, So-called Fibrohistiocytic, Muscular, Lymphomatous, Neurogenic, Hair Matrix, and Uncertain Origin. RadioGraphics 0: e36-e [Abstract] [Full Text]  
• Diomedi-Camassei, F., McDowell, H. P., De Ioris, M. A., Uccini, S., Altavista, P., Raschella, G., Vitali, R., Mannarino, O., De Sio, L., Cozzi, D. A., Donfrancesco, A., Inserra, A., Callea, F., Dominici, C. (2008). Clinical Significance of CXC Chemokine Receptor-4 and c-Met in Childhood Rhabdomyosarcoma. Clin. Cancer Res. 14: 4119-4127 [Abstract] [Full Text]  
• Arndt, V., Lacour, B., Steliarova-Foucher, E., Spix, C., Znaor, A., Pastore, G., Stiller, C., Brenner, H. (2007). Up-to-date monitoring of childhood cancer long-term survival in Europe: tumours of the sympathetic nervous system, retinoblastoma, renal and bone tumours, and soft tissue sarcomas. Ann Oncol 18: 1722-1733 [Abstract] [Full Text]  
• Nabarro, S., Himoudi, N., Papanastasiou, A., Gilmour, K., Gibson, S., Sebire, N., Thrasher, A., Blundell, M. P., Hubank, M., Canderan, G., Anderson, J. (2005). Coordinated oncogenic transformation and inhibition of host immune responses by the PAX3-FKHR fusion oncoprotein. JEM 202: 1399-1410 [Abstract] [Full Text]